A global database of COVID-19 vaccinations

Article Biochemistry & Molecular Biology

Looking beyond COVID-19 vaccine phase 3 trials

Jerome H. Kim et al.

Summary: Following the announcement of COVID-19 vaccine efficacy in clinical trials, a comprehensive strategy is needed for global vaccination, including manufacturing, support, supply coordination, equitable distribution, and logistics. Additionally, addressing scientific questions to improve vaccine efficacy is crucial for ending the pandemic effectively and efficiently.

NATURE MEDICINE (2021)

Add to Collection

News Item Medicine, General & Internal

Covid-19: Medical community split over vaccine interval policy as WHO recommends six weeks

Elisabeth Mahase

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Article Medicine, General & Internal

Covid-19 vaccination: What’s the evidence for extending the dosing interval?

Gareth Iacobucci et al.

BMJ-British Medical Journal (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey

Susan M. Sherman et al.

Summary: Most UK adults have a positive attitude towards being vaccinated against COVID-19, with factors such as general vaccine beliefs and attitudes, information sufficiency, and risk perception influencing vaccination intention. Intention to be vaccinated may be influenced by factors such as vaccine safety, perception of COVID-19 risk, among others.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission

Jeffrey D. Sachs et al.

LANCET (2021)

Add to Collection

Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Last-Mile Logistics of Covid Vaccination - The Role of Health Care Organizations

Thomas H. Lee et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Covid-19: How the UK vaccine rollout delivered success, so far

Chris Baraniuk

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Letter Public, Environmental & Occupational Health

An interactive website tracking COVID-19 vaccine development

Madhumita Shrotri et al.

LANCET GLOBAL HEALTH (2021)

Add to Collection

Article Psychology, Biological

A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker)

Thomas Hale et al.

Summary: The Oxford COVID-19 Government Response Tracker (OxCGRT) records data on 19 different government COVID-19 policy indicators for over 190 countries. Covering closure and containment, health and economics measures, it creates an evidence base for effective responses.

NATURE HUMAN BEHAVIOUR (2021)

Add to Collection

Article Health Policy & Services

Israel's rapid rollout of vaccinations for COVID-19

Bruce Rosen et al.

Summary: Israel has stood out for its rapid and effective COVID-19 vaccine rollout, with factors contributing to its success falling into categories of long-standing characteristics, health-system specific features, and recent efforts specific to the vaccination campaign. The synergy created among these facilitating factors has been crucial in Israel's success, distinguishing it from other high-income countries like the US, the UK, and Canada that have faced slower vaccine distribution due to lacking some of these factors.

ISRAEL JOURNAL OF HEALTH POLICY RESEARCH (2021)

Add to Collection

Editorial Material Immunology